CRI's new website that seeks to engage, educate, and empower patients and their loved ones to learn more about cancer immunotherapy as a treatment option across numerous tumor types.
Cancer patients, donors, scientists, and other supporters all stand behind the Cancer Research Institute. Read their stories and learn about what motivates each of us to keep fighting against cancer.
By running in a marathon or hosting a bake sale, you can make a real difference for our scientists in the fight against cancer and allow them to bring newer immunotherapies to more patients.
We gratefully accept donations made in memory or in honor of a loved one. Your gift will be acknowledged to whomever you specify.
A $1 million challenge to spur innovative solutions to challenges in cancer immunotherapy research.
Curious about the latest developments in cancer immunotherapy research? Listen in as leading scientists discuss immune-based treatments across numerous cancer types in our free "Cancer Immunotherapy and You" webinar series.
When the Cancer Research Institute was founded in 1953, we knew then that immune-based treatments would transform cancer medicine. In more than six decades since, we've made numerous groundbreaking discoveries that have given more patients new hope today.
Welcome to the Cancer Research Institute blog. Here we share the latest updates on the field of cancer immunotherapy from CRI, including scientific breakthroughs, news stories, and program announcements. We invite your comments and encourage you to share these stories with your friends.
You can receive notifications of new posts by subscribing to our blog. Just click the RSS icon in the upper right corner.
November 2, 2016
Our CEO joins Loncar Investments to ring in a day of trading at the exchange focused on technology and innovation.
The past week saw an explosion of media coverage on the power of cancer immunotherapy. NBC Nightly News, the New York Times, the Wall Street Journal, and other major media outlets covered the remarkable results from a groundbreaking immunotherapy clinical trial.
antibody, cancer immunotherapy, in the news, melanoma, vaccine
antibody, anti-CTLA-4, anti-PD-1, immunotherapy, Jedd Wolchok, melanoma, yervoy
awareness, cancer, immunotherapy
community fundraising, young philanthropists
Xueling Wu, a CRI postdoctoral fellow from 2003-2006, has recently been appointed an assistant professor at the Aaron Diamond AIDS Research Center at The Rockefeller University.
AIDS, fellows, vaccine
A breakthrough new treatment that genetically modifies immune cells in cancer patients is showing tremendous promise in helping adults with an aggressive form of leukemia.
gene therapy, leukemia, T cell therapy
The New York Observer named Cancer Research Institute Young Philanthropists Council chair Alexis Feldman as one of its "20 Under 40" Top Young Philanthropists in its 2013 annual philanthropy supplement.
in the news, young philanthropists
Mark Sundrud, a former CRI Irvington Postdoctoral Fellow (2006-2009) has been appointed assistant professor in the Department of Cancer Biology at The Scripps Research Institute.
Cancer Research Institute has launched a new website that features expert information on the latest breakthroughs in cancer immunotherapy, helpful patient information, videos, infographics, and more.
The Winter 2013 issue of The Researcher, CRI's print newsletter, is now available online.